Business Context and Reporting Period
This Form 8-K Current Report was filed by Aveanna Healthcare Holdings, Inc. on November 1, 2024. The filing discloses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the appointment of a new director and does not contain financial statement data.
Material Changes
The material change reported is the appointment of Brent Layton to the Board of Directors to fill a vacancy. Mr. Layton was appointed as a Class III director and a member of the Audit Committee. His term will last until the 2027 Annual Meeting of Stockholders.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or management commentary regarding business performance in this filing. The Board determined that Mr. Layton is independent under SEC and Nasdaq rules. He will participate in standard non-employee director compensation arrangements as described in the Company's 2024 Proxy Statement. No transactions involving Mr. Layton requiring disclosure under Item 404(a) of Regulation S-K were identified.
Key Facts for Investor Verification
- Brent Layton, currently CEO of Sharecare, was appointed to the Board of Directors on November 1, 2024.
- Mr. Layton joins the Audit Committee and serves as a Class III director.
- The appointment was made to fill a vacancy with no special arrangements or understandings disclosed.
- Mr. Layton brings over twenty years of experience at Centene Corporation, most recently as President and COO.
- Compensation will follow the standard non-employee director structure outlined in the April 1, 2024 Proxy Statement.